Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Eur J Obstet Gynecol Reprod Biol

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    April 2021
  1. CHOU HH, Chen WC, Yang LY, Huang HJ, et al
    Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:13-20.
    PubMed     Abstract available


  2. ATHEY RA, Macdonald MC, Jha S
    Stage of ovarian cancer at diagnosis. Does presentation as an emergency make a difference?
    Eur J Obstet Gynecol Reprod Biol. 2021;261:7-11.
    PubMed     Abstract available


    March 2021
  3. GKROZOU F, Pappa C, Tsonis O, Dimitriou E, et al
    Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:99-104.
    PubMed     Abstract available


    February 2021
  4. CAPMAS P, Suarthana E, Tulandi T
    Further evidence that endometriosis is related to tubal and ovarian cancers: A study of 271,444 inpatient women.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:105-109.
    PubMed     Abstract available


    November 2020
  5. ZHANG JL, Li DF, Li DY, Ma LG, et al
    A rare malignant transformation of endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 27. pii: S0301-2115(20)30741.
    PubMed    


  6. BOURDEL N, Huchon C, Abdel Wahab C, Azais H, et al
    Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 20. pii: S0301-2115(20)30758.
    PubMed     Abstract available


  7. CARBONE MV, Cavaliere AF, Fedele C, Vidiri A, et al
    Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:326-332.
    PubMed     Abstract available


  8. ZILLIOX M, Lecointre L, Azais H, Ballester M, et al
    Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:412-418.
    PubMed     Abstract available


  9. VOUTSADAKIS IA
    A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:172-178.
    PubMed     Abstract available


  10. TANG X, Zhang X, Liu X, Zheng T, et al
    A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:256-262.
    PubMed     Abstract available


  11. FONNES T, Telle IO, Forsse D, Falck R, et al
    Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:25-31.
    PubMed     Abstract available


    October 2020
  12. KONSGEN D, Klinkmann G, Kaul A, Diesing K, et al
    Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:154-159.
    PubMed     Abstract available


  13. KOLEHMAINEN AM, Pasanen AM, Koivisto-Korander RL, Butzow RC, et al
    Molecular characterization in the prediction of disease extent in endometrial carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020 Oct 16. pii: S0301-2115(20)30669.
    PubMed     Abstract available


  14. ZHAO J, Wu J, Zuo W, Kang S, et al
    A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:183-189.
    PubMed     Abstract available


  15. FERRARI F, Ficarelli S, Forte S, Valenti G, et al
    Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:211-221.
    PubMed     Abstract available


    September 2020
  16. YOSHIHARA M, Tamauchi S, Iyoshi S, Kitami K, et al
    Does uterine preservation affect survival outcomes of patients with stage I ovarian sex cord-stromal cell tumours? A multi-institutional study.
    Eur J Obstet Gynecol Reprod Biol. 2020;254:52-56.
    PubMed     Abstract available


    August 2020
  17. CHEN S, Yang B, Fan J
    Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:266-272.
    PubMed     Abstract available


    July 2020
  18. KHIAT S, Provansal M, Bottin P, Saias-Magnan J, et al
    Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:65-70.
    PubMed     Abstract available


    June 2020
  19. PERGIALIOTIS V, Thomakos N, Frountzas M, Haidopoulos D, et al
    Perioperative blood transfusion and ovarian cancer survival rates: A meta-analysis based on univariate, multivariate and propensity score matched data.
    Eur J Obstet Gynecol Reprod Biol. 2020;252:137-143.
    PubMed     Abstract available


    April 2020
  20. DELANGLE R, Rossard L, Cirier J, Delvallee J, et al
    Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?
    Eur J Obstet Gynecol Reprod Biol. 2020 Apr 24. pii: S0301-2115(20)30234.
    PubMed     Abstract available


  21. HSIAO SM
    Letter to the Editor on "A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy".
    Eur J Obstet Gynecol Reprod Biol. 2020;247:257.
    PubMed    


    March 2020
  22. CHEVROT A, Hequet D, Fauconnier A, Huchon C, et al
    Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:227-232.
    PubMed     Abstract available


    January 2020
  23. RUDAITIS V, Mikliusas V, Januska G, Jukna P, et al
    The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:26-31.
    PubMed     Abstract available


  24. NASIOUDIS D, Mastroyannis SA, Haggerty AF, Giuntoli RL 2nd, et al
    Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:63-70.
    PubMed     Abstract available


    December 2019
  25. LECOINTRE L, Velten M, Lodi M, Saadeh R, et al
    Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).
    Eur J Obstet Gynecol Reprod Biol. 2019;245:64-72.
    PubMed     Abstract available


    November 2019
  26. OTIFY M, Laios A, Elshamy T, D'Angelo A, et al
    A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:120-127.
    PubMed     Abstract available


  27. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed     Abstract available


  28. RETTENMAIER MA, Micha JP, Bohart R, Goldstein BH, et al
    A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:101-105.
    PubMed     Abstract available


    October 2019
  29. NAMAZOV A, Gemer O, Helpman L, Hag-Yahia N, et al
    The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:120-124.
    PubMed     Abstract available


  30. VAN HEERDEN J, Tjalma WA
    The multidisciplinary approach to ovarian tumours in children and adolescents.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:103-110.
    PubMed     Abstract available


    September 2019
  31. BENITO V, Lubrano A, Andujar M, Mori M, et al
    Management of endometrial cancer in patients aged 80 years and older: Identifying patients who may benefit from a curative treatment.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:36-42.
    PubMed     Abstract available


  32. WANG Y, Sun H, Yu A, Zhu T, et al
    Association between chemotherapy and disease-specific survival in women with borderline ovarian tumors: A SEER-based study.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:92-98.
    PubMed     Abstract available


  33. NASIOUDIS D, Holcomb K
    Incidence of isolated para-aortic lymph node metastasis in early stage endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;242:43-46.
    PubMed     Abstract available


    August 2019
  34. REISER E, Aust S, Seebacher V, Reinthaller A, et al
    Gamma-glutamyltransferase as a preoperative differential diagnostic marker in patients with adnexal mass.
    Eur J Obstet Gynecol Reprod Biol. 2019;239:16-20.
    PubMed     Abstract available


    July 2019
  35. TIMMERMANS M, Zwakman N, Sonke GS, Van de Vijver KK, et al
    Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:364-369.
    PubMed     Abstract available


  36. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
    A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:310-315.
    PubMed     Abstract available


  37. TOZZI R, Casarin J, Baysal A, Pinelli C, et al
    Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:215-219.
    PubMed     Abstract available


  38. FALCONE F, Normanno N, Losito NS, Scognamiglio G, et al
    Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:220-225.
    PubMed     Abstract available


    June 2019
  39. ZHU X, Yang H, Lang J, Zhang Y, et al
    Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:103-108.
    PubMed     Abstract available


    May 2019
  40. NASIOUDIS D, Wilson E, Mastroyannis SA, Latif NA, et al
    Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors.
    Eur J Obstet Gynecol Reprod Biol. 2019;238:86-89.
    PubMed     Abstract available


    April 2019
  41. BOGANI G, Matteucci L, Tamberi S, Ditto A, et al
    RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy.
    Eur J Obstet Gynecol Reprod Biol. 2019;237:93-99.
    PubMed     Abstract available


    March 2019
  42. LAVOUE V, Huchon C, Akladios C, Alfonsi P, et al
    Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 15. pii: S0301-2115(19)30128.
    PubMed     Abstract available


  43. FISCHETTI A, Rutigliani M, Romano N, Marinaro EL, et al
    Imaging findings of ovarian leiomyosarcoma with histopathologic correlations.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 12. pii: S0301-2115(19)30116.
    PubMed     Abstract available


    January 2019
  44. KAJIYAMA H, Suzuki S, Yoshikawa N, Kawai M, et al
    Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2019;234:131-136.
    PubMed     Abstract available


    October 2018
  45. OTSUKA I
    Development and rapid growth of retroperitoneal leiomyoma during carboplatin/paclitaxel chemotherapy in an ovarian cancer patient.
    Eur J Obstet Gynecol Reprod Biol. 2018 Oct 19. pii: S0301-2115(18)31050.
    PubMed    


  46. HUANG J, Chen J, Huang Q
    Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2018;231:35-42.
    PubMed     Abstract available


    September 2018
  47. BASTU E, Onder S, Demiral I, Ozsurmeli M, et al
    Distinguishing the progression of an endometrioma: Benign or malignant?
    Eur J Obstet Gynecol Reprod Biol. 2018;230:79-84.
    PubMed     Abstract available


  48. HABEK D, Cenkovcan M, Jandric D, Stanic G, et al
    Ovarian hemangioma with Meigs' syndrome.
    Eur J Obstet Gynecol Reprod Biol. 2018 Sep 5. pii: S0301-2115(18)30961.
    PubMed    


    June 2018
  49. FELSINGER M, Minar L, Weinberger V, Rovny I, et al
    Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;228:154-160.
    PubMed     Abstract available


  50. SONG T, Kim MK, Jung YW, Yun BS, et al
    The role of appendectomy in patients with mucinous borderline ovarian tumors.
    Eur J Obstet Gynecol Reprod Biol. 2018;229:112-116.
    PubMed     Abstract available


    May 2018
  51. POUNDS R, Phillips A, Kehoe S, Nevin J, et al
    Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.
    Eur J Obstet Gynecol Reprod Biol. 2018;226:47-53.
    PubMed     Abstract available


    April 2018
  52. LOAEC C, Bats AS, Ngo C, Cornou C, et al
    Dual docking robotic surgical staging for high risk endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:79-83.
    PubMed     Abstract available


  53. LEVIN G, Zigron R, Haj-Yahya R, Matan LS, et al
    Granulosa cell tumor of ovary: A systematic review of recent evidence.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:57-61.
    PubMed    


  54. TIMMERMANS M, Sonke GS, van Driel WJ, Lalisang RI, et al
    Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
    Eur J Obstet Gynecol Reprod Biol. 2018;223:98-102.
    PubMed     Abstract available


    March 2018
  55. NTOUMANOGLOU-SCHUIKI A, Tomasch G, Laky R, Taumberger N, et al
    Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: What do national societies advise?
    Eur J Obstet Gynecol Reprod Biol. 2018;225:110-112.
    PubMed     Abstract available


  56. CAPOTE S, Sanchez-Iglesias JL, Cubo-Abert M, De la Torre J, et al
    Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2018 Mar 28. pii: S0301-2115(18)30154.
    PubMed    


  57. SADEGHI R
    Sentinel lymph node biopsy in ovarian cancers: Are intracervical injections necessary?
    Eur J Obstet Gynecol Reprod Biol. 2018 Mar 20. pii: S0301-2115(18)30128.
    PubMed    


  58. RAJANBABU A, Agarwal R
    A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
    Eur J Obstet Gynecol Reprod Biol. 2018;224:77-80.
    PubMed     Abstract available


  59. MENDIVIL AA, Abaid LN, Brown JV 3rd, Mori KM, et al
    The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;224:29-32.
    PubMed     Abstract available


    January 2018
  60. LI J, Zhu Q, Yang B, Ning C, et al
    Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2018;222:151-154.
    PubMed     Abstract available


  61. RUAN L, Xie Y, Liu F, Chen X, et al
    Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Eur J Obstet Gynecol Reprod Biol. 2018;222:31-38.
    PubMed     Abstract available


    December 2017
  62. DUFFY S, Day EK, Bryson G, Millan D, et al
    Malignant tumours arising within mature cystic teratomas of the ovary: Prevalence and clinical outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2017 Dec 21. pii: S0301-2115(17)30571.
    PubMed    


  63. VAN NIEKERK CC, van Dijck JAAM, Verbeek ALM
    The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
    Eur J Obstet Gynecol Reprod Biol. 2017;221:17-22.
    PubMed     Abstract available


  64. UCCELLA S, Gisone B, Stevenazzi G, Ghezzi F, et al
    Laparoscopic sentinel node detection with ICG for early ovarian cancer: Description of a technique and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2017 Dec 6. pii: S0301-2115(17)30543.
    PubMed    


    November 2017
  65. VIMERCATI A, Suma C, Cicinelli E, Resta L, et al
    Title ultrasound features of ovarian melanoma metastases: The "Golf ball" aspect.
    Eur J Obstet Gynecol Reprod Biol. 2017 Nov 23. pii: S0301-2115(17)30511.
    PubMed     Abstract available


  66. CORMIO G, Seckl MJ, Loizzi V, Resta L, et al
    Increased human Chorionic Gonadotropin levels five years before diagnosis of an ovarian dysgerminoma.
    Eur J Obstet Gynecol Reprod Biol. 2017 Nov 10. pii: S0301-2115(17)30510.
    PubMed    


  67. ABBASI S, Rasouli M
    Dermatoglyphic patterns on fingers and gynecological cancers.
    Eur J Obstet Gynecol Reprod Biol. 2017;222:39-44.
    PubMed     Abstract available


    October 2017
  68. VERMEULEN CKM, Tadesse W, Timmermans M, Kruitwagen RFPM, et al
    Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;219:100-105.
    PubMed     Abstract available


  69. KURU O, Boyraz G, Uckan H, Erturk A, et al
    Retroperitoneal nodal metastasis in primary adult type granulosa cell tumor of the ovary: Can routine lymphadenectomy be omitted?
    Eur J Obstet Gynecol Reprod Biol. 2017;219:70-73.
    PubMed     Abstract available


    July 2017
  70. WEN Q, Shao Z, Zhang P, Zhu T, et al
    Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:85-91.
    PubMed     Abstract available


  71. CHENE G, Chauvy L, Buenerd A, Moret S, et al
    Dynamic real-time in vivo confocal laser endomicroscopy of the fallopian tube during laparoscopy in the prevention of ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:18-23.
    PubMed     Abstract available


    June 2017
  72. YILDIRIM N, Akman L, Acar K, Demir S, et al
    Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2017;215:55-61.
    PubMed     Abstract available


    May 2017
  73. GORDTS S, Campo R, Bogers JP, Tanos V, et al
    Transvaginal laparoscopy: A minimally invasive approach to obtain brush cytology of the Fallopian tube.
    Eur J Obstet Gynecol Reprod Biol. 2017;212:80-84.
    PubMed     Abstract available


    January 2017
  74. SAIJO M, Nakamura K, Masuyama H, Ida N, et al
    Glasgow prognostic score is a prognosis predictor for patients with endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2017;210:355-359.
    PubMed     Abstract available


    December 2016
  75. GHANEM AI, Khan NT, Mahan M, Ibrahim A, et al
    The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis.
    Eur J Obstet Gynecol Reprod Biol. 2016;210:225-230.
    PubMed     Abstract available


    November 2016
  76. ROMANOWICZ H, Michalska MM, Samulak D, Malinowski J, et al
    Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2016;208:36-40.
    PubMed     Abstract available


    October 2016
  77. KASPER SM, Dueholm M, Marinovskij E, Blaakaer J, et al
    Imaging diagnostics in ovarian cancer: magnetic resonance imaging and a scoring system guiding choice of primary treatment.
    Eur J Obstet Gynecol Reprod Biol. 2016;210:83-89.
    PubMed     Abstract available


  78. ISROW D, Burmeister C, Hanna RK, Elshaikh MA, et al
    Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:115-120.
    PubMed     Abstract available


  79. BAR D, Lavie O, Stein N, Feferkorn I, et al
    The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2016 Oct 14. pii: S0301-2115(16)30914.
    PubMed     Abstract available


  80. NI T, Sun X, Shan B, Wang J, et al
    Detection of circulating tumour cells may add value in endometrial cancer management.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:1-4.
    PubMed     Abstract available


  81. RUIZ M, Labauge P, Louboutin A, Limot O, et al
    External validation of the MR imaging scoring system for the management of adnexal masses.
    Eur J Obstet Gynecol Reprod Biol. 2016;205:115-9.
    PubMed     Abstract available


    August 2016
  82. RUIZ MP, Morales-Ramirez PB, Dziadek OL, Algren SD, et al
    Epithelial ovarian cancer and type of peritoneal insult: a case-control study.
    Eur J Obstet Gynecol Reprod Biol. 2016;205:170-173.
    PubMed     Abstract available


    June 2016
  83. RADHOUANE A, Mayada S, Khaled N
    Lymphangioma of the ovary: etiology and management.
    Eur J Obstet Gynecol Reprod Biol. 2016 Jun 29. pii: S0301-2115(16)30296.
    PubMed     Abstract available


  84. SINHA A, Drews F, Lim K, Pugh ND, et al
    Retrospective analysis of suspicious pelvic masses using the Pelvic Mass Index (PMI) scoring system from 2007 to 2014.
    Eur J Obstet Gynecol Reprod Biol. 2016;201:79-84.
    PubMed     Abstract available


    May 2016
  85. GURASLAN H, Dogan K
    Management of unilocular or multilocular cysts more than 5 centimeters in postmenopausal women.
    Eur J Obstet Gynecol Reprod Biol. 2016;203:40-43.
    PubMed     Abstract available


    March 2016
  86. SHIBER LJ, Gregory EJ, Gaskins JT, Biscette SM, et al
    Adnexal masses requiring reoperation in women with previous hysterectomy with or without adnexectomy.
    Eur J Obstet Gynecol Reprod Biol. 2016;200:123-127.
    PubMed     Abstract available


    February 2016
  87. BUDA A, Ghelardi A, Fruscio R, Guelfi F, et al
    The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: a double institution observational study.
    Eur J Obstet Gynecol Reprod Biol. 2016;197:156-8.
    PubMed     Abstract available


    November 2015
  88. SECKIN KD, Karsli MF, Yucel B, Bestel M, et al
    The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
    Eur J Obstet Gynecol Reprod Biol. 2015;196:60-63.
    PubMed     Abstract available


    October 2015
  89. TJALMA WA
    Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2015 Oct 27. pii: S0301-2115(15)00363.
    PubMed    


    August 2015
  90. PECES RAMA A, Llanos Llanos MC, Sanchez Ferrer ML, Alcazar Zambrano JL, et al
    Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.
    Eur J Obstet Gynecol Reprod Biol. 2015;195:7-11.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: